Mixing 5 mg tirzepatide with bacteriostatic water: what the UK guidance actually says

You've got a vial, a syringe and instructions from a forum, stop here

Picture the scenario: you've come across tirzepatide sold as a lyophilised (freeze-dried) powder in a small glass vial, alongside a bottle of bacteriostatic water and a set of syringes. The instructions look precise. The seller seems professional. The price was significantly lower than anything you'd seen at a regulated UK pharmacy. This is exactly the situation the MHRA has been flagging since counterfeit and compounded weight-loss injectables began flooding UK online markets.

Bacteriostatic water is a sterile diluent used in clinical and laboratory settings to reconstitute powdered medicines. In countries where compounded tirzepatide is produced and sold (notably the United States, before FDA restrictions tightened), reconstitution guides became widely shared. Those guides have migrated to UK forums, but the context hasn't travelled with them. The UK has no licensed compounded tirzepatide product. Any vial of tirzepatide powder arriving in the UK is either a grey-market import, an unlicensed compound, or counterfeit. The MHRA raided a Northampton site in October 2025 that was producing fake tirzepatide pens, and enforcement in 2025 alone intercepted roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million. You can report a suspect seller via the MHRA's Yellow Card scheme.

The risks with a vial product are specific. If you have somehow ended up with a powder vial and want to understand what mixing 10mg tirzepatide with bacteriostatic water actually involves, reading through that process makes clear just how many points of error exist, from concentration calculations to sterility, that cannot be reliably controlled outside a licensed manufacturing environment. And if the active ingredient isn't pharmaceutical-grade tirzepatide at all, you have no way of knowing what you're injecting.

What the licensed 5 mg Mounjaro pen actually looks like

The genuine Mounjaro 5 mg pen is a pre-filled KwikPen containing a clear, colourless to slightly yellow solution. You attach a needle, dial nothing, and inject subcutaneously into the abdomen, thigh or upper arm. The pen holds four weekly doses. There is no powder, no vial, no water, no syringe to fill. The NHS medicines page for tirzepatide describes this clearly and is worth bookmarking as a reference alongside the Patient Information Leaflet that comes in the box.

The 5 mg strength sits within a licensed titration schedule starting at 2.5 mg. The starter pen is used for the first month to allow the body to adjust, and 5 mg is typically the second step, though the prescriber decides the pace based on how you're responding. A question our prescribers hear most weeks is whether moving faster through the doses will speed up results; the honest answer is that the schedule exists to reduce nausea and other gastrointestinal effects, not to slow progress artificially.

If you want to understand how the tirzepatide 5 mg dose fits into the overall treatment journey, that page covers it in full. Storage for the genuine pen is straightforward: refrigerate at 2–8°C. For the exact permitted room-temperature window if you're travelling or the pen has been out of the fridge, refer to your Patient Information Leaflet, that detail is specific to the product batch and pen format, and it's the one source that's always accurate.

How to tell if the tirzepatide you've been offered is legitimate

The simplest check is this: did you receive a prescription from a clinician who assessed you, issued by a pharmacy you can verify? Every legitimate supply of Mounjaro in the UK passes through that gateway. You can check any online pharmacy on the GPhC register, it takes thirty seconds and tells you whether the service is registered and trading lawfully.

Red flags that suggest you're looking at an unlicensed product include: the medicine comes as a powder or vial rather than a pre-filled pen; you're given mixing instructions; the seller operates via social media or an unregistered website; the price is dramatically lower than current UK market rates; or you're not asked to complete a clinical assessment before purchase. Selling prescription medicines without proper licensing is illegal in the UK, and buying from such sources leaves you with no clinical oversight, no genuine supply chain, and no recourse if something goes wrong.

If you're currently using a vial product and have concerns about it, the right step is to contact a prescriber or your GP. The nume support team is available seven days a week if you want to ask questions before starting anything.

Getting tirzepatide the right way in the UK

The route to licensed tirzepatide in the UK is a prescription, following a proper clinical assessment. At nume, that process starts with a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician, not automated decision-making. Once approved as clinically suitable, treatment is dispatched the same working day for free next-working-day delivery by DPD, in plain packaging.

You can read more about weight-loss treatment options generally, or explore the full Mounjaro overview to understand how tirzepatide works as a dual GIP and GLP-1 receptor agonist, what the clinical trial results showed, and how the eligibility criteria apply. The FAQ page also covers common questions about the consultation process. If you're ready to see whether you qualify, a prescriber will assess your full picture, BMI, medical history and any other relevant factors. No vials. No mixing. Just a licensed medicine, clinically supervised, through a pharmacy you can verify.